View Section: Company Analysis
Aclaris Rating
AC
ACRS stock rating score is 27/100. Aclaris is aExtremely Risky Investment.
The in-depth assessment covers such aspects as the profitability and solvency of the company, management efficiency, and growth sustainability. Our rating serves as an answer to whether the company`s shares are generally reasonable for purchase. The higher company rating score is, the more stock is attractive for investment.
Eyestock Rating
Last update 08.11.2024
27/100
Low score
Rating Breakdown
Profitability score
-9
/25
Solvency score
46
/25
Efficiency score
-25
/25
Stability score
14
/25
Aclaris Therapeutics Inc Rewards and Warnings
The assessment of the quality of a business is based on quantitative analysis of 10 key financials taken from the company's statements. Pay close attention to the cons, if any, before making a decision.
Financial
Check
Value
Net Profit Margin
-137 %
Earnings quality
—
—
Gross Margin
54 %
Aclaris Therapeutics Inc's Historical Rating
How has the company's valuation changed in the past?
A quick analysis will help you understand how stable financial indicators are overall.
Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Discover High-rated Companies
View Section: Valuation